Sitemap
Events
Portfolio
- Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B
- Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
- Design of LRRK2 crystallographic surrogate
- Chk1 pre-clinical candidate
- PDHK - application of off-rate screening (ORS)
- Hsp90 oral backup pre-clinical candidate
- Hsp90 phase II candidate
- Bcl-2 phase I candidate
- Mcl-1 in vivo active inhibitor